Sunday, 01 November 2026 01:00 PM
Class Action
NEW YORK CITY, NY / ACCESS Newswire / November 1, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of argenx SE ("argenx" or "the Company") (NASDAQ:ARGX). Investors who purchased argenx securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/cases/argenx-se-argx-investigation.
argenx Investigation Details
On October 8, 2026, Argenx issued a press release "announcing that it will discontinue the Phase 3 UNITY study of efgartigimod subcutaneous (SC) (efgartigimod alfa and hyaluronidase-qvfc) in adults with moderate-to-severe Sjögren's disease." The Company said that "[t]he decision is based on the recommendation from an Independent Data Monitoring Committee (IDMC) to stop the study for futility following an interim analysis" after "concludeing that the UNITY study is unable to meet its primary endpoint." Following this news, argenx SE's stock price fell $109.81 per share, or 11.83%, to close at $818.63 per share on October 8, 2026.
What's Next for argenx Investors?
If you are aware of any facts relating to this investigation or purchased argenx securities, you can assist this investigation by visiting the firm's site: bgandg.com/cases/argenx-se-argx-investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911
No Cost to argenx Investors
We, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for argenx Securities Investigation?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
SOURCE: Bronstein, Gewirtz & Grossman, LLC